Huntsworth PLC operates within the Public relations services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huntsworth PLC with three other
miscellaneous service companies in Europe:
Bachem Holding AG
sales of 208.60 million Swiss Francs [US$205.72 million]
of which 84%
was Active Pharmaceutical Ingredients),
Pharma Mar SA
(193.82 million Euro [US$205.10 million]
of which 65%
was Biotech Sector), and
Cello Group PLC
(£157.32 million [US$192.08 million]
of which 59%
was Cello Signal).
During the year ended December of 2015, sales at
Huntsworth PLC were £168.40 million (US$205.61 million).
a very small
increase of 1.6%
versus 2014, when the company's sales were £165.73 million.
Despite this increase, sales are still
below the level achieved in 2013, when Huntsworth PLC
reported sales of £172.40 million.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Huntsworth PLC had sales
of £173.60 million.
Sales of Huntsworth Health saw an increase
that was more than double the company's growth rate: sales were up
21.1% in 2015, from
£59.71 million to £72.32 million.
Huntsworth PLC also saw significant increases in sales in
Red (up 4.2% to £12.83 million)
Not all segments of Huntsworth PLC experienced an increase in sales in 2015:
sales of Grayling fell 10.7% to £63.21 million.
Huntsworth PLC also experienced decreases in sales in
Cdr (down 8.7% to £20.04 million)